James L. Gulley

Results: 41



#Item
1MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and development

MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and development

Add to Reading List

Source URL: www.mdanderson.org

Language: English - Date: 2015-05-09 06:45:52
2Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-based

Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-based

Add to Reading List

Source URL: www.mdanderson.org

Language: English - Date: 2015-05-09 06:44:39
3Microsoft Word - ScientificLeadershipBiosFinal042409.doc

Microsoft Word - ScientificLeadershipBiosFinal042409.doc

Add to Reading List

Source URL: www.canaryfoundation.org

Language: English - Date: 2014-01-07 19:14:49
4Published in June[removed]Clinical Trial Solutions Copyright 2014 by PharmaLinx LLC

Published in June[removed]Clinical Trial Solutions Copyright 2014 by PharmaLinx LLC

Add to Reading List

Source URL: www.wwctrials.com

Language: English - Date: 2014-06-03 16:37:54
5restifo-CD8_TcellDiff_v02

restifo-CD8_TcellDiff_v02

Add to Reading List

Source URL: home.ccr.cancer.gov

Language: English - Date: 2012-02-01 13:39:40
6The Newsletter of the NIH Alumni Association date  Summer 1998

The Newsletter of the NIH Alumni Association date Summer 1998

Add to Reading List

Source URL: history.nih.gov

Language: English - Date: 2013-05-17 17:02:47
7PROSTVAC Presentation for the RAC James L. Gulley M.D., Ph.D., F.A.C.P. Director, Clinical Trials Group & Deputy Chief, Laboratory of Tumor Immunology and Biology

PROSTVAC Presentation for the RAC James L. Gulley M.D., Ph.D., F.A.C.P. Director, Clinical Trials Group & Deputy Chief, Laboratory of Tumor Immunology and Biology

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 12:40:12
8NATIONAL INSTITUTES OF HEALTH

NATIONAL INSTITUTES OF HEALTH

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-03-19 13:20:26
9RAC Meeting Agenda - June 7-9, 2011

RAC Meeting Agenda - June 7-9, 2011

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-03-19 13:21:14
10Microsoft Word - ICRW2008 Final Speaker Bios[removed]doc

Microsoft Word - ICRW2008 Final Speaker Bios[removed]doc

Add to Reading List

Source URL: chordomafoundation.org

Language: English - Date: 2011-10-14 16:42:14